euro adhoc: november AG
Management Changes
CEO Dr. Claus Müller resigns from
office
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
C.E.O. Interviews
03.12.2007
Erlangen, 3rd December 2007. Dr. Claus Müller has asked the supervisory board of november AG to release him from all duties related to his present office as CEO of the company for health reasons with immediate effect. The supervisory board has granted the request. Dr. Claus Müller will step down as managing director of IBL Hamburg, identif GmbH and directif GmbH as well effective from the same day.
end of announcement euro adhoc 03.12.2007 10:46:11
Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de
Branche: Biotechnology
ISIN: DE000A0S9N72
WKN: A0S9N7
Index: CDAX, Technologie All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade